Bioreactor– tag –
-
Market Trends
Precision Fermentation Powers All G’s Industrial-Scale Launch of Animal-Free Lactoferrin ‘LFX Apoprotein’ in US Market
AgFunderNews Australia Overview Australian biotechnology firm All G has commercially launched LFX Apoprotein, a novel animal-free, low-iron lactoferrin produced via precision fermentation, in the U.S. market. Currently scaled at a 60,000... -
Market Trends
Continuous Bioprocessing Delivers Significant Gains in Biopharmaceutical Manufacturing Efficiency and Cost Reduction, Driven by 500L Single-Use Perfusion Bioreactors
BioProcess International USA Overview Biopharmaceutical manufacturers are rapidly adopting continuous bioprocessing, integrating upstream cell culture and downstream operations to boost productivity, cut costs, and reduce facility footpr... -
Cell Culture Technology
Roche Leverages NVIDIA AI Digital Twins for GLP-1 Biomanufacturing Innovation, Targeting 25-40% Capacity Increase and 15-20% Lead Time Reduction
IntuitionLabs Switzerland Overview Roche announced the integration of NVIDIA's AI and digital twin technologies, including BioNeMo, to optimize its biomanufacturing processes for GLP-1 pharmaceuticals. This initiative aims to create virt... -
Market Trends
APAC’s Bioprocessing Technology Ready, Regulatory Certainty Needed for Continuous Manufacturing Investment; China/Korea CDMOs Lead Adoption
BioProcess International USA Overview A BioProcess International article analyzes regulatory challenges for continuous and intensified bioprocessing adoption in the Asia Pacific (APAC) region. While hardware and software for perfusion bi... -
Cell Culture Technology
Continuous Chromatography & ICH Q13 Overcome Downstream Purification Challenges Amplified by Upstream Intensification
Separation Science Global Overview According to Separation Science, upstream bioreactor intensification, including N-1 perfusion seeding and high-density fed-batch, is creating new challenges for downstream purification. Continuous purif... -
New Technology
MDPI Study Achieves mAb Yield Maximization and Cost Reduction Through Dynamic Simulation and Optimization of Fed-Batch Bioreactors
MDPI Global Overview A research paper published in MDPI demonstrates the effectiveness of dynamic simulation and optimization methods for fed-batch bioreactors in monoclonal antibody (mAb) production. Addressing the need for higher yield... -
Market Trends
Bora Biologics Expands US Biologics Manufacturing Capacity to 20,000 Liters with New Rockville, Maryland Site
PharmaSource USA Overview Bora Biologics has expanded its U.S. drug substance manufacturing platform by adding a new site in Rockville, Maryland. This expansion increases its single-use bioreactor capacity to 20,000 liters, with scalabil... -
Drug Discovery & DDS
Cytovance Biologics Enhances Biologics Manufacturing Process Development with Perfusion Capabilities to Boost Productivity
Cytovance Biologics USA Overview Cytovance Biologics, a CDMO, has expanded its upstream process development services by integrating perfusion capabilities. This technological addition enables higher productivity, extended cell culture du... -
New Technology
Tetra Pak Unveils Bioreactor RF, Revolutionizing Precision Fermentation Scaling with Patented Magnetic Agitation System
Food and Drink Technology UK Overview Tetra Pak has launched its first dedicated industrial bioreactor, the 'Bioreactor RF,' specifically designed to address key scaling bottlenecks in precision fermentation. The bioreactor features a pa... -
New Technology
ArXiv Paper Unveils ‘Agentic Self-Driving Lab’ with LLMs and Bayesian Optimization to Accelerate Antibody Bioprocess, Drastically Reducing Experimental Costs and Timelines
ArXiv (Preprint server) USA Overview A paper published on ArXiv proposes an innovative 'agentic self-driving lab' concept, combining large language models (LLMs) and Bayesian optimization. Aimed at accelerating scientific discovery, incl...